SOURCE: Antisoma plc

September 16, 2008 09:45 ET

Antisoma to present at Merrill Lynch and UBS Global Pharmaceutical Conferences

LONDON, UK--(Marketwire - September 16, 2008) -

16 September 2008, London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that it will present at the following Pharmaceutical/Life Sciences conferences.

Glyn Edwards, CEO, will present at the Merrill Lynch Global Pharmaceutical Conference in London on 18th September at 09.50 BST.

Dr Daniel Elger, Director of Communications, will present at the UBS Global Life Sciences Conference in New York on 23rd September 2008 at 09.00 EDT (14.00 BST).

Webcasts of both presentations will be available on Antisoma's website at

For live viewing of the webcasts, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Enquiries: Daniel Elger Director of Communications Antisoma plc +44 7909 915 068

Background on Antisoma Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit for further information about Antisoma.


Copyright © Hugin AS 2008. All rights reserved.

Contact Information